Evidence map›Paper›PMID 38738803›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2024

Inorganic Biomaterials Shape the Transcriptome Profile to Induce Endochondral Differentiation.

Aparna Murali, Anna M Brokesh, Lauren M Cross, Anna L Kersey, Manish K Jaiswal, Irtisha Singh, Akhilesh Gaharwar

Erratum issuedAbstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Materiobiology in the omics era.Materials today. Bio · 2025
    Review
  4. Article
  5. Inorganic Biomaterials Shape the Transcriptome Profile to Induce Endochondral Differentiation.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Aparna MuraliDepartment of Biomedical Engineering, College of Engineering, Texas A&M University, College Station, TX, 77843, USA.
Anna M BrokeshDepartment of Biomedical Engineering, College of Engineering, Texas A&M University, College Station, TX, 77843, USA.
Lauren M CrossDepartment of Biomedical Engineering, College of Engineering, Texas A&M University, College Station, TX, 77843, USA.
Anna L KerseyDepartment of Biomedical Engineering, College of Engineering, Texas A&M University, College Station, TX, 77843, USA.
Manish K JaiswalDepartment of Biomedical Engineering, College of Engineering, Texas A&M University, College Station, TX, 77843, USA.
Irtisha SinghDepartment of Biomedical Engineering, College of Engineering, Texas A&M University, College Station, TX, 77843, USA.
Akhilesh GaharwarDepartment of Biomedical Engineering, College of Engineering, Texas A&M University, College Station, TX, 77843, USA.ORCID 0000-0002-0284-0201

Funding

Mineralomics: Designing mineral based therapeutics to control and direct cell functionDP2EB026265 · NIBIB · TEXAS ENGINEERING EXPERIMENT STATION · PI GAHARWAR, AKHILESH K. · 2017 to 2021
$2.4M
Osteoinductive Nanosilicate-Based Biomaterials for In Situ Craniomaxillofacial Bone RegenerationR01DE032031 · NIDCR · TEXAS ENGINEERING EXPERIMENT STATION · PI CARL A. GREGORY, Akhilesh K. Gaharwar · 2024 to 2026
$1.7M
Impact of Emotions on Treatment Decisions About Low-Risk Thyroid CancerK08CA230204 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI PITT, SUSAN C · 2018 to 2023
$1.4M
Investigating the role Ikaros variants in multiple myeloma pathophysiology and drug sensitivityR01CA282251 · NCI · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI Irtisha Singh · 2024 to 2026
$1.1M
Investigating Pathophysiology of Glioma Stem Cells in 3D Bioprinted Vascularized Glioblastoma ModelR21NS121945 · NINDS · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI SINGH, IRTISHA · 2022 to 2023
$403k
Cancer Prevention and Research Institute of Texas CPRIT RP230204Congressionally Directed Medical Research Programs W81XWH2210932NCI NIH HHS R01 CA282251NCI NIH HHS R01CA282251NIBIB NIH HHS DP2 EB026265NIDCR NIH HHS R01 DE032031NINDS NIH HHS R21 NS121945
6 · The paper itself

Abstract

Minerals play a vital role, working synergistically with enzymes and other cofactors to regulate physiological functions including tissue healing and regeneration. The bioactive characteristics of mineral-based nanomaterials can be harnessed to facilitate in situ tissue regeneration by attracting endogenous progenitor and stem cells and subsequently directing tissue-specific differentiation. Here, cellular responses of human mesenchymal stem/stromal cells to traditional bioactive mineral-based nanomaterials, such as hydroxyapatite, whitlockite, silicon-dioxide, and the emerging synthetic 2D nanosilicates are investigated. Transcriptome sequencing is utilized to probe the cellular response and determine the significantly affected signaling pathways due to exposure to these inorganic nanomaterials. Transcriptome profiles of stem cells treated with nanosilicates reveals a stabilized skeletal progenitor state suggestive of endochondral differentiation. This observation is bolstered by enhanced deposition of matrix mineralization in nanosilicate treated stem cells compared to control or other treatments. Specifically, use of 2D nanosilicates directs osteogenic differentiation of stem cells via activation of bone morphogenetic proteins and hypoxia-inducible factor 1-alpha signaling pathway. This study provides  insight into impact of nanomaterials on cellular gene expression profile and predicts downstream effects of nanomaterial induction of endochondral differentiation.

Indexed as

Biocompatible MaterialsCell DifferentiationMesenchymal Stem CellsTranscriptomeCells, CulturedGene Expression ProfilingHumansNanostructuresOsteogenesisBiocompatible Materialsbiomaterialsnanomaterialsregenerative medicineRNA‐seqstem cells

Identifiers

PMID38738803
PMCPMC11304299

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.